Jan 6, 2025 04:00PM
Jan 6, 2025 04:00PM
Jan 2, 2025 08:00PM
Nov 14, 2024 06:58AM
Nov 13, 2024 04:00PM
Aug 13, 2024 04:00PM
Aug 13, 2024 04:00PM ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results
May 29, 2024 07:00AM
Mar 11, 2024 08:00AM
Nov 7, 2023 04:05PM
Aug 14, 2023 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All